Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 2.6B | 2.5B | 2.5B | 2.9B |
Cost of revenue | 634.5M | 654.4M | 651.8M | 821.9M |
Gross profit | 1.9B | 1.9B | 1.9B | 2.1B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 237.5M | 243.1M | 227.7M | 234.3M |
Other operating expenses | -55.8M | -17.4M | 5.1M | -1.9M |
Operating income | 1.3B | 1.2B | 1.1B | 1.3B |
Non operating interest income | ||||
Income | 26.9M | 32.1M | 37.7M | 43.7M |
Expense | 325.3M | 321.2M | 356.8M | 365.4M |
Other income expense | -338.2M | 428.2M | -269.6M | 65.8M |
Pretax income | 617.5M | 1.3B | 550.5M | 1.0B |
Tax provision | 118.9M | 75.2M | 122.4M | 120M |
Net income | 498.6M | 1.2B | -780.4M | 908.4M |
Basic EPS | — | 2.6 | -1.7 | 1.9 |
Diluted EPS | — | 2.6 | -1.7 | 1.9 |
Basic average shares | — | 467.3M | 467.2M | 467.0M |
Diluted average shares | — | 468.4M | 468.3M | 467.8M |
EBITDA | 1.8B | 1.7B | 1.8B | 2.0B |
Net income from continuing op. | 498.6M | 1.2B | -780.4M | 908.4M |
Minority interests | -9.9M | -900K | -11.9M | -8.1M |
Preferred stock dividends | — | — | — | — |